Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: ELUSYS THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2021-08-06 to 2023-09-30
Current total value of award: $79947200
Description: MANUFACTURE AND DELIVERY OF ANTHIM (OBILTOXAXIMAB)600MG/6ML INJECTION, AN ANTHRAX ANTITOXIN COUNTERMEASURE